AKT1 and neoplasm: The hyperactive PI3K/Akt signaling generated metabolic byproducts to stimulate ROS production, and further research focusing on the association of PIK3CA-mutant tumors and redox homeostasis could contribute suppress tumor growth and overcome drug resistance [35].